During the corresponding time, Champions Oncology Inc recorded a revenue increase by 8.84 % year on year, sequentially revenue grew by 10.09 %. While revenue at the Champions Oncology Inc 's corporate clients
Champions Oncology Inc's Comment on Sales, Marketing and Customers
The company provides licensed access to model-specific data for research purposes. Its software-as-a-service offering, the Lumin Bioinformatics platform, is sold through annual subscriptions and supports computational cancer research. A sales team of approximately 45 professionals markets services directly to pharmaceutical and biotechnology companies. The research services team focuses on acquiring new customers and increasing revenue from existing clients by promoting the adoption of research platforms. The company's drug discovery and development efforts target therapeutic areas such as targeted therapy with drug conjugates, immuno-oncology, and cell therapy. For the fiscal year ended April 30, 2026, the company reported revenues of approximately $59.4 million, representing a 4% increase from the previous year.
Champions Oncology Inc’s Comment on Sales, Marketing and Customers
The company provides licensed access to model-specific data for research purposes. Its software-as-a-service offering, the Lumin Bioinformatics platform, is sold through annual subscriptions and supports computational cancer research. A sales team of approximately 45 professionals markets services directly to pharmaceutical and biotechnology companies. The research services team focuses on acquiring new customers and increasing revenue from existing clients by promoting the adoption of research platforms. The company's drug discovery and development efforts target therapeutic areas such as targeted therapy with drug conjugates, immuno-oncology, and cell therapy. For the fiscal year ended April 30, 2026, the company reported revenues of approximately $59.4 million, representing a 4% increase from the previous year.
Sources:
Champions Oncology Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Champions Oncology Inc’s corporate clients.
For your research, we’ve provided 9 tables on Champions Oncology Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
92.94 %